The medical technology group of Siemens Healthineers wants to expand its business in the United States with a billion-dollar Acquisition. The cancer-care specialized company, Varian is intended to be purchased for 16.4 billion dollars (14 billion euros), announced the MDax-listed subsidiary of Siemens on Sunday in Erlangen. The Varian shareholders will receive 177,50 dollars per share. This is about a quarter more than the shares on Friday had cost the evening. The Board of Directors of the American group approved the Plan and recommends to shareholders, the offer to accept.
Varian was in the last fiscal year, approximately $ 3.2 billion and achieved an operating margin of 17 percent. Finance Siemens wants to Healthineers the Takeover about half through loans and half by new equity, the Erlangen on the issue of new shares, obtain want. The acquisition of Varian should be completed, subject to the approval of the Varian stockholders, the issuance of regulatory approvals and other customary closing conditions, is expected in the first half of the calendar year 2021. Siemens Healthineers 43,95 € -0.26 (-0,59%) Xetra price data
The Siemens AG, welcomed the planned acquisition, and said that the strategy "Vision 2020+" will be consistently maintained. Through the planned capital increase of Siemens Healthineers AG, at the Siemens AG will not participate, reducing the share of Siemens AG at the Siemens Healthineers AG from 85 percent to 72 percent. Siemens 108,32 EUR -1,52 (-1,38%) Xetra
- 1 day
- 6 months
Siemens Healthineers is 2018 listed on the stock exchange gone and since then is legally independent of Siemens AG. This holds, however, 85 percent of the Healthineers shares. The company employs approximately 50 000 employees at locations in more than 70 countries.Siemens Healthineers sees significant improvement in the fourth quarter of
Siemens Healthineers also reckons in the last three months of the fiscal year 2019/2020, according to the last corona-related weakness again, with better shops. The enterprise dares now to make a forecast for the entire fiscal year. "For the fourth quarter, we expect a significant improvement in our business development compared to the third quarter," said Siemens Healthineers-in-chief Bernd Monday on Sunday in Erlangen.
Siemens Healthineers attributed the new forecast to the end of September, end-of-fiscal year 2020 with a stable sales on a comparable Basis - excluding Acquisition and currency effects. The special effects, adjusted earnings per share to be between 1.54 and 1.62 m (previous year: 1,70 Euro). Originally, Siemens Healthineers in the case of the two values was expected to increase, this forecast is but the beginning of may because of the corona-related uncertainties withdrawn.
In the third quarter, sales declined compared to the previous year, section by 7.2 per cent to 3.31 billion euros, on a comparable Basis, the decline amounted to 6.9 percent. - Adjusted for special effects earnings before interest and taxes (Ebit) fell by 15 percent to 461 million euros, adjusted earnings per share fell about a fifth to 30 cents. Thus, the group fulfilled the revenue expectations of the experts and exceeded the operating result.
Also of interest: economic output shrinks by almost 33 percent After the economic shock in the United States characterized the next shock from the ECB: First Inflation, then a new monetary order is coming - what does this mean for savers FOCUS Online Daniel Stelter in an Interview: ECB: First Inflation, then a new monetary order is coming - what the saver is calledcvh/dpa Updated Date: 02 August 2020, 06:26